Diet · GLP-1s
A quarter of the weight lost is lean tissue, and that is also true on a dummy shot
The muscle loss argument about these drugs is usually made with the wrong number. The split of lean to fat in the weight people lose is ordinary, and the drug barely changes it. The amount is what changed. The two things get reported as if they were one.
The Archive’s position
This is opinion, not a finding. Everything else on this page is the evidence.
The muscle and hair loss people get on a GLP-1 is mostly not the drug doing something to them. It is what happens when appetite disappears and someone simply stops eating instead of eating differently. Hit your protein target and keep lifting, and most of it can be avoided.
Why we hold it
- The lean mass ratio is the same on the drug and on dummy shots. In the SURMOUNT-1 scans, about 25% of lost weight was lean tissue in both groups, so the drug is not changing what weight loss is made of. It is changing how much of it there is.
- Fast weight loss by any route does this. The same hair shedding is well known after weight loss surgery, on a much bigger scale than the 3.9% seen with these drugs. That points at the speed of the loss, and at what is being eaten, rather than at the drug.
- Two 2026 reviews disagree about whether these drugs are worse than dieting for lean mass. They agree completely about what helps. Adding weight training gave the lowest share of weight lost as lean tissue in both, 7.7% in one and 17.5% in the other, against roughly 22 to 26% for dieting alone. When two reviews that contradict each other point the same way on one factor, that factor is the one to act on.
- Losing your appetite removes the signal that normally makes people eat. Nobody plans an 800 calorie day. It happens because nothing feels urgent. A protein target is a number you hit on purpose, which is exactly what is needed when hunger stops reminding you.
Where this goes beyond the evidence
No study has tested this advice. The one study that added protein without training found nothing, and it is quoted everywhere as proof that protein does not help. But it compared 52 with 77 grams a day on a 600 calorie diet, both around or below the RDA. So it tested a low intake against a slightly less low one, and it cannot speak to 150 or 200 grams. That cuts both ways. It does not disprove the position, and it does not support it either. The study that would settle it is recruiting now and reports in 2029. It will assign people on a GLP-1 to weight training, to 1.6 g/kg of protein, to both, or to neither. The claim that this is mostly avoidable is a fair inference from the training data plus how the body works. It is not a measured result, and the evidence is stronger for the training half of the advice than for the protein half.
Who this is not for
Anyone reading this as a reason to stop or change a prescribed medicine. Nothing here is about whether to take these drugs, which is a decision to make with a doctor. There is also a real gap underneath all of it. Across 35 trials, not one reported an objective measure of physical function. So what any of this lean mass change means for strength or daily life has mostly not been measured.
Two corrections that change the size of the problem
The first is the share versus the amount. In the SURMOUNT-1 scans, about 75% of the weight lost was fat and 25% was lean. That split was the same in the group on a dummy shot. So the drug is not changing what the lost weight is made of. It is producing a lot more of it, 21.3% of body weight against 5.3%. A normal share of an unusual amount still removes an unusual amount of lean tissue. Both sides of this argument tend to pick whichever of those two facts suits them.
The second is that lean mass is not muscle. The lean part of a DXA scan includes organs, connective tissue, skin and body water, and muscle is roughly half of it. So every headline percentage in this discussion is about double the figure for muscle itself. In SURPASS-3, thigh muscle was measured directly by MRI and compared with data that followed large groups of people over time. The amount lost was broadly what the link between body weight and muscle would predict. And the fat mixed into the muscle got better.
What survives both corrections is still worth acting on. Losing that much weight that fast takes real tissue with it, and the studies say clearly which lever moves that number most.
What was measured
About 25% of the weight lost was lean mass, on the drug and on dummy shots alike
Who was studied
160 people in the SURMOUNT-1 body scan group, scanned at the start and at week 72, 124 on tirzepatide and 36 on dummy shots
People on tirzepatide lost 21.3% of their body weight, and people on dummy shots 5.3%. Of the weight lost, roughly 75% was fat and 25% was lean mass in both groups, and that split held across sex, age and how much weight people lost. The ratio is not the drug's doing.
Study in peopleBody composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight (2025)What this does not show
That the drug is therefore neutral for muscle. The same ratio applied to four times the weight loss means four times the lean tissue lost. And this study measured lean mass with a DXA body scan, not muscle directly.
In studies with big weight loss, the drug groups lost a bigger share as lean tissue
Who was studied
1,334 people across 21 trials, limited to programs that achieved at least 10% weight loss, measured by DXA, CT or MRI scans
The share of lost weight that was lean mass: 33.3% on incretin drugs (the GLP-1 family), 34.2% after weight loss surgery, 22.3% on diet alone, and 7.7% on diet plus exercise. Exercise, not the drug and not the diet, is what moves this number most.
Review of studiesEffects of incretin-based therapies, diet and exercise interventions, and bariatric surgery on fat-free mass in adults with overweight or obesity: a systematic review and meta-analysis (2026)What this does not show
A fair comparison between these routes. Nobody was assigned by chance to surgery, a drug or a gym, so this pools groups from separate studies in different people. It is also disputed. A second 2026 review, four times larger and without the 10% weight loss limit, found no real difference between these drugs and lifestyle change at all. Read the two together rather than picking one.
A larger review found no difference between the drugs and lifestyle change
Who was studied
15,782 people across 20 trials of semaglutide, tirzepatide, liraglutide or intensive lifestyle programs, with body make-up measured by DXA or MRI scans
Lean mass was 35.2% of weight lost on semaglutide, 25.4% on tirzepatide and 26.8% on liraglutide. Lifestyle programs came out at 26.2%, and the difference from the drugs could have been chance. Adding weight training to a lifestyle program gave the best figure in the analysis, at 17.5%.
Review of studiesLean mass changes with incretin therapy versus lifestyle intervention: a systematic review and meta-analysis of randomised controlled trials (2026)What this does not show
Agreement with the other review on this page, and that is the point of showing both. This one included studies with any amount of weight loss, while the other required at least 10%, and they reach opposite conclusions about whether the drugs are worse than dieting. What they do agree on is the direction of the only lever either tested: weight training gave the lowest share of weight lost as lean tissue in both. Note too that the 17.5% figure was measured in people not taking a GLP-1, so applying it to someone on one goes beyond the data.
When muscle was scanned directly, the loss matched what the weight change predicts
Who was studied
246 adults with type 2 diabetes in the SURPASS-3 MRI group with a usable week 52 scan. Thigh muscle volume was measured by MRI and compared against long-term UK Biobank data.
Muscle volume fell, but broadly in line with the normal link between weight change and muscle volume, not beyond it. Fat inside the muscle, which is a measure of muscle quality, improved.
Study in peopleTirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial (2025)What this does not show
Anything about strength or function. Volume and fat inside muscle are structure, not strength. And this is an after-the-fact look at a study where everyone knew which drug they were on, paid for by the drug's maker.
Adding protein to a very low calorie diet, without training, changed nothing
Who was studied
108 adults with overweight or obesity given 52 or 77 grams of protein a day on a 600 to 700 calorie diet for 8 weeks, with lean mass measured by DXA scan
Lean mass fell about 6% in both groups, and the share of weight loss that was lean tissue was the same, at 27%. The energy burned at rest fell 9 to 10% either way.
Study in peopleA protein-supplemented very-low-calorie diet does not mitigate reductions in lean mass and resting metabolic rate in subjects with overweight or obesity: a randomized controlled trial (2021)What this does not show
That protein does not matter, and this is the most misread result in the area. Both groups were far below every intake on our protein page. 77 grams for a 100 kg adult is about 0.77 g/kg, which is the RDA. This study compared a low intake with a slightly less low one and found no difference between them. It did not test a high protein intake, and nobody lifted anything.
Hair loss is real, and the base rate is 3.9%
Who was studied
4,114 people taking GLP-1 drugs across nine treatment studies, seven of them trials with a comparison group
Hair loss was 3.25 times as likely as on dummy shots, with a likely range of 1.44 to 7.36, and 3.59 times when limited to trials in people with overweight or obesity. In studies with no comparison group, 3.9% of people had hair loss.
Review of studiesGlucagon-like peptide-1 receptor agonists and hair loss: a systematic review and meta-analysis (2026)What this does not show
How it happens, or that the drug causes it directly rather than the speed of the weight loss. A tripled risk on a 3.9% base is roughly three or four people in a hundred, not most people. And hair loss on this scale is well known after fast weight loss by any route, including surgery.
The thing nobody measured
Across thirty-five head-to-head studies of these drugs, not one reported a hands-on test of physical function. Every figure argued over on this topic is a scan. Whether the lost lean tissue costs anybody strength, grip, walking speed or the ability to get out of a chair has simply not been tested, apart from a handful of side checks.
Where function was measured for other reasons, it got better, not worse. That is what you would expect when someone carrying a lot of extra weight loses a lot of it. That is reassuring, but it is not the same as having asked the question.
One study is designed to answer the version of this that matters here. It splits people on a GLP-1 into four groups: strength training, a higher protein target, both, or neither. Its main measure is the size of the thigh muscle on MRI, and it is paid for by nobody who sells any of this. It reports in 2029. Until then, anyone telling you confidently that protein fixes this, including us, is reasoning past the evidence rather than from it.
Questions people ask about this
- Do GLP-1 drugs cause muscle loss?
- They cause weight loss. About a quarter of the weight lost is lean tissue, whether it comes off on the drug or on a dummy shot. That share is normal. What is not normal is the amount. In the SURMOUNT-1 scans, the drug group lost 21.3% of body weight, against 5.3% on the dummy shot. So the same share means roughly four times the lean tissue.
- Is lean mass the same thing as muscle?
- No, and mixing them up inflates every figure in this discussion. On a DXA scan (a body scan that splits fat from lean tissue), lean mass includes organs, connective tissue, skin and body water as well as muscle. Muscle is roughly half of it. When thigh muscle was measured directly by MRI instead of estimated from DXA, the amount lost matched what the link between body weight and muscle predicts.
- Will eating more protein stop it?
- It is the sensible thing to do, and it has not been proven for this situation. The study usually cited against it compared 52 with 77 grams of protein a day, both around the RDA (the official daily amount), and found no difference. That tests a low intake against a slightly less low one, not a high one. The study that would actually answer this reports in 2029.
- What has the largest measured effect on lean mass during weight loss?
- Strength training. Across studies reaching at least 10% weight loss, fat-free mass made up 22.3% of the weight lost on diet alone and 7.7% on diet plus exercise. No change to the diet measured so far moves the number that much.
- Is the hair loss permanent?
- The published drug studies show the risk is raised, roughly tripled on a base rate of 3.9%. They do not show why it happens or how it plays out. The pattern reported after fast weight loss in general is a shedding phase that starts a couple of months in and then recovers. The autoimmune kind of hair loss, alopecia areata, has consistently not been found to go up. Anything more specific than that is not supported by the studies right now.
Related
Peri and post menopause change the muscle conversation on a GLP-1. Those questions live in the peri FAQ.